Results 81 to 90 of about 3,206 (156)

Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the acute myeloid leukemia burden. [PDF]

open access: yesBlood, 2023
Biondi M   +16 more
europepmc   +1 more source

Acute exercise mobilizes NKT-like cells with a cytotoxic transcriptomic profile but does not augment the potency of cytokine-induced killer (CIK) cells. [PDF]

open access: yesFront Immunol, 2022
Zúñiga TM   +7 more
europepmc   +1 more source

Macrophage-derived pro-inflammatory cytokines augment the cytotoxicity of cytokine-induced killer cells by strengthening the NKG2D pathway in multiple myeloma

open access: yesScientific Reports
Multiple myeloma (MM) is a clonal hematologic malignancy characterized by low rate of complete remissions. Cytokine-induced killer (CIK) cell therapy has shown promising benefits in MM treatment.
Peng Chen   +7 more
doaj   +1 more source

Cytokine-induced killer cells are type II natural killer T cells

open access: yesGMS German Medical Science, 2007
Background: Until now, cytokine-induced killer (CIK) cells were assumed to be part of the type I natural killer T (NKT) cell population, but it was not yet investigated if this is correct.
Schmidt-Wolf, Ingo G.H.   +3 more
doaj  

Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System. [PDF]

open access: yesMol Ther, 2020
Rotiroti MC   +18 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy